CINECA IRIS Institutional Research Information System

MEROLA, Aristide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.367
EU - Europa 2.806
AS - Asia 1.368
SA - Sud America 127
OC - Oceania 81
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 11
Totale 8.785
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.247
CN - Cina 729
IT - Italia 675
SE - Svezia 286
IE - Irlanda 275
DE - Germania 270
FR - Francia 241
JP - Giappone 228
GB - Regno Unito 187
ES - Italia 123
FI - Finlandia 115
IN - India 102
NL - Olanda 100
CA - Canada 97
PL - Polonia 93
AT - Austria 84
BR - Brasile 82
AU - Australia 73
KR - Corea 70
TR - Turchia 57
BE - Belgio 56
UA - Ucraina 49
VN - Vietnam 45
TW - Taiwan 39
CH - Svizzera 35
PT - Portogallo 32
DK - Danimarca 29
GR - Grecia 28
RO - Romania 25
AR - Argentina 22
SG - Singapore 22
CZ - Repubblica Ceca 20
MX - Messico 20
RU - Federazione Russa 19
CL - Cile 14
BG - Bulgaria 13
HK - Hong Kong 11
IL - Israele 11
TH - Thailandia 9
NZ - Nuova Zelanda 8
PH - Filippine 8
EU - Europa 7
RS - Serbia 7
CO - Colombia 6
EE - Estonia 6
IR - Iran 6
IS - Islanda 6
SI - Slovenia 6
SN - Senegal 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
EG - Egitto 5
ID - Indonesia 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
HR - Croazia 4
HU - Ungheria 4
TN - Tunisia 4
AP - ???statistics.table.value.countryCode.AP??? 3
CY - Cipro 3
EC - Ecuador 3
MA - Marocco 3
MY - Malesia 3
SV - El Salvador 3
KZ - Kazakistan 2
MD - Moldavia 2
MT - Malta 2
OM - Oman 2
SA - Arabia Saudita 2
A1 - Anonimo 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
GE - Georgia 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
SD - Sudan 1
Totale 8.785
Salva come PNG Salva come JPEG
Città #
Chandler 424
Beijing 374
Dublin 270
Fairfield 268
Houston 218
Torino 214
Ashburn 211
Redwood City 208
Ann Arbor 163
Wilmington 159
Woodbridge 132
Seattle 125
Villeurbanne 115
Cambridge 111
Dearborn 110
Nyköping 109
Medford 81
Princeton 81
Jacksonville 74
Vienna 72
Pisa 64
Warsaw 58
Boston 43
Shanghai 40
Madrid 37
Tokyo 37
Milan 35
Boardman 33
New York 32
Dong Ket 31
Duncan 28
Guangzhou 28
Taipei 28
Rome 25
Ottawa 24
Fremont 22
Helsinki 22
London 20
Nanjing 20
Brussels 18
Hangzhou 18
Toronto 18
Chengdu 17
Düsseldorf 17
Mumbai 16
Turin 16
Istanbul 15
São Paulo 15
Wuhan 14
Jinan 13
Paris 13
Santiago 13
Changsha 12
Huntington Station 12
Nagoya 12
Washington 12
Chicago 11
Norwalk 11
Polska 11
Saint Paul 11
Seoul 11
Barcelona 10
Chongqing 10
Fort Worth 10
Hefei 10
New Delhi 10
Phoenix 10
Singapore 10
Zhengzhou 10
Amsterdam 9
Buenos Aires 9
Cincinnati 9
Cleveland 9
Fukuoka 9
Fuzhou 9
Gent 9
Groslay 9
Hamburg 9
Los Angeles 9
Minneapolis 9
San Diego 9
Sydney 9
Dallas 8
Edinburgh 8
Kunming 8
Melbourne 8
Napoli 8
Oxford 8
Renton 8
Rio De Janeiro 8
Rochester 8
Utrecht 8
Valencia 8
Würzburg 8
Baton Rouge 7
Berlin 7
Buffalo 7
Copenhagen 7
Essen 7
Frankfurt am Main 7
Totale 4.787
Salva come PNG Salva come JPEG
Nome #
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. 684
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 641
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 608
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study. 563
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study 452
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience 425
Levodopa-carbidopa intestinal gel infusion and weight loss in Parkinson's disease 364
Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study. 323
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 307
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome? 255
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements. 250
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset? 243
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients 243
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 206
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment 132
Personality and Deep Brain Stimulation of the subthalamic nucleus in Parkinson's disease 113
Short-term efficacy of ultramicronized palmitoylethanolamide in peripheral neuropathic pain. 91
Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside 87
Cortical pathology in multiple sclerosis: expression of glutamate transporter EAAT2 86
Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients 84
Neuronal and synaptic pathology in grey matter demyelinating lesions in multiple sclerosis 83
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 82
Advanced therapies in Parkinson's disease: Long-term retrospective study 79
Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study 79
3 years comparison between duodopa and Deep Brain Stimulation 78
CIDP-like neuropathies in graft versus host disease 75
Neuronal and synaptic pathology in the demyelinating lesions of grey matter in multiple sclerosis 73
Neuronal and synaptic pathology in the demyelinating lesions of grey matter in multiple sclerosis 72
Patterns of diffuse inflammation and axonal injury in multiple sclerosis normal appearing white matter 71
Transdermal rotigotine in dihydropteridine reductase deficiency 71
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 70
Comparison of subthalamic nucleus Deep Brain Stimulation and Duodopa in the treatment of advanced Parkinson's disease. 69
Corticla pathology in multiple sclerosis: expression of glutamate transporter EAAT2 68
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 68
Orthostatic hypotension in Parkinson disease: Impact on health care utilization 68
Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming 68
Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter 67
Continuous intraduodenal L-dopa/carbidopa gel infusion improves nocturnal sleep in advanced Parkinson’s disease 65
Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response 63
Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: A long-term prospective assessment 63
The dominant subthalamic nucleus: A gait analysis study 63
Autonomic dysfunction in Parkinson's disease: A prospective cohort study 62
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation 61
Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic? 61
Clinical efficacy of different stimulation frequencies on dyskinesias and dystonias in subthalamic nucleus deep brain stimulation patients with parkinson's disease 58
Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data 57
Effects of 80 Hz stimulation on gait in STN-DBS treated PD patients 57
A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion 57
Parkinsonism–hyperpyrexia syndrome and deep brain stimulation 56
Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease 52
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis 49
Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit 48
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation 47
Subcutaneous "bolus" immunoglobulin dose in CIDP: A proof-of concept study 43
Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease 42
Peripheral neuropathy as marker of severe Parkinson's disease phenotype 42
Parkinson's clinical features after 30 years of disease: A study from patients treated by subthalamic nucleus stimulation 40
Electrophysiological Predictors of Clinical Outcome in Traumatic Neuropathies: A Multicenter Prospective Study 40
Telemedicine in Neurological Disorders: Opportunities and Challenges 40
Effect of subthalamic deep brain stimulation on posture in Parkinson's disease: A blind computerized analysis 40
Machine learning applied to ambulatory blood pressure monitoring: a new tool to diagnose autonomic failure? 39
Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition 37
Orthostatic hypotension and REM sleep behaviour disorder: Impact on clinical outcomes in α-synucleinopathies 36
Functional neurological disorders in Parkinson disease 36
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials 36
Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study 35
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 35
Subthalamic deep brain stimulation and trunk posture in Parkinson's disease 34
Prospective assessment of peripheral neuropathy in duodopa treated patients 33
Levodopa-Induced Neuropathy: A Systematic Review 32
Subthalamic deep brain stimulation and levodopa in Parkinson’s disease: a meta-analysis of combined effects 27
Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases 26
Differential impact of individual autonomic domains on clinical outcomes in Parkinson's disease 22
Reply to: "Autonomic dysfunction in Parkinson's disease: The hidden game changer?" 21
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease 18
Totale 9.071
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.543
article - articoli 0
book - libri 0
conference - conferenze 2.709
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.252
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019438 0 0 0 0 0 0 0 0 0 121 213 104
2019/20201.456 67 69 80 174 132 183 151 147 153 134 85 81
2020/20211.108 106 175 96 66 80 107 65 70 101 80 69 93
2021/20221.051 79 39 46 121 55 54 52 54 44 76 240 191
2022/20231.437 129 102 49 119 146 361 94 116 126 56 94 45
2023/2024693 112 117 49 54 94 118 33 36 15 65 0 0
Totale 9.071